Alcyomics ltd

Alcyomics Ltd. is a clinical research organization (CRO) based in Newcastle, UK, that provides non-animal human in vitro assays for safety and efficacy testing. The company specializes in immunotoxicology and drug development, utilizing its patented Skimune® platform, a human skin explant assay. By using human tissue-based models, the technology accurately predicts human immune responses to various compounds, including small molecules, biologics, monoclonal antibodies, and advanced therapies, serving as a reliable alternative to traditional animal testing.

The services provided by Alcyomics help pharmaceutical, biotechnology, and cosmetics clients de-risk their product portfolios, improve clinical trial outcomes, and accelerate time-to-market. Their assays are highly customizable and have been used in various applications ranging from early-stage drug discovery and safety assessments for first-in-human studies to efficacy testing for immunomodulators and cellular therapies. The company operates under Good Laboratory Practice and ISO9001 standards, with its research extensively published in peer-reviewed journals to support regulatory submissions and clinical trial applications.